Storage and Research Use of Human Bio-specimens From Melanoma Patients and Clinical Testing for Assignment of Treatment

Vanderbilt University Medical Center

Status: Enrolling

Conditions: Melanoma

Treatments: Other: Tissue and blood collection

Study type: Observational

Funder types: Other

Identifiers

NCT01205815

VICC MEL 09109

Details and patient eligibility

About

The purpose of this research is to identify biological characteristics occurring in the initiation and progression of melanoma.

Enrollment: 3,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria

• Pathologically-proven diagnosis of melanoma.
• Patient must have a test or procedure that has the potential to provide left-over tissue that can be banked for future research purposes OR the patient has already had a diagnostic or therapeutic procedure but who has not yet been approached to participate is also eligible.

Exclusion criteria

• Any patient with significant contraindications to venipuncture (e.g., severe anemia) will be excluded from blood collection procedures. However, if the patient provides consent and a paraffin-embedded block or 10-15 unstained slides of their tissue diagnosis, they will not be excluded from this protocol.
• Any patient unable or unwilling to provide consent.